Phase 2 study of idarubicin in pediatric brain tumors: Pediatric Oncology Group study POG 9237

Zo Ann E. Dreyer, Richard P. Kadota, Clinton F. Stewart, Henry S. Friedman, Donald H. Mahoney, Larry E. Kun, Charles W. McCluggage, Peter C. Burger, James Kepner, Richard L. Heideman

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Phase 2 study of idarubicin in pediatric brain tumors: Pediatric Oncology Group study POG 9237'. Together they form a unique fingerprint.

Medicine & Life Sciences